Long Term Study of the Safety of OXC XR as in Pediatric Epilepsy Subjects

Open-label, Pharmacokinetic, Safety and Efficacy Study of Adjunctive Brivaracetam in Children With Epilepsy.

NCT00422422 ·Status: COMPLETED ·Phase: PHASE2

EXTENT: EXtended Tolerability and Efficacy of a Novel Formulation of Oxcarbazepine in a Trial in Partial Epilepsy

NCT00391534 ·Status: TERMINATED ·Phase: PHASE3

Pediatric Epilepsy Study

NCT00050947 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as Adjunctive Therapy in Pediatric Subjects With Epilepsy

NCT01284530 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

NCT03650452 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures

NCT00275925 ·Status: COMPLETED ·Phase: PHASE4

Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy

NCT01364597 ·Status: COMPLETED ·Phase: PHASE3

A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on Padsevonil

NCT03695094 ·Status: COMPLETED ·Phase: PHASE1

Long-term Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures

NCT01051193 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Extension Study to Evaluate NBI-827104 in Pediatric Participants With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep

NCT05301894 ·Status: TERMINATED ·Phase: PHASE2

Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures

NCT00437281 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR

NCT00368069 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures

NCT00975715 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study to Evaluate NBI-921352 as Adjunctive Therapy in Subjects With SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE)

NCT04873869 ·Status: TERMINATED ·Phase: PHASE2

A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures

NCT04715646 ·Status: RECRUITING ·Phase: PHASE3

Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

NCT05067634 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With Epilepsy

NCT00961441 ·Status: COMPLETED ·Phase: PHASE2

A Study to Test the Long-term Safety, Tolerability and Efficacy of Brivaracetam in Study Participants 2 to 26 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

NCT05109234 ·Status: COMPLETED ·Phase: PHASE3

Conversion to Monotherapy Study With Keppra XR for Partial Seizures

NCT00419094 ·Status: COMPLETED ·Phase: PHASE3

An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy

NCT00210652 ·Status: COMPLETED ·Phase: PHASE2

Pharmacokinetics and Safety Study of Diazepam Buccal Film (DBF) in Pediatric Subjects With Epilepsy

NCT03222349 ·Status: COMPLETED ·Phase: PHASE2

Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects

NCT02724423 ·Status: COMPLETED ·Phase: PHASE1

A Study to Investigate How Effective, Safe and Tolerable the Drug NBI-921352 is When Used With Anti-seizure Medications in Adults With Focal Onset Seizures

NCT05159908 ·Status: COMPLETED ·Phase: PHASE2

An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy

NCT00210522 ·Status: COMPLETED ·Phase: PHASE2

A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

NCT06315322 ·Status: RECRUITING ·Phase: PHASE3